Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and removed Revision: v3.2.0 along with government funding notices; these changes update site metadata rather than the study details.
    Difference
    0.3%
    Check dated 2025-11-24T18:17:22.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    New version entries in the record history show updated study and recruitment statuses for NCT03976362.
    Difference
    0.0%
    Check dated 2025-11-03T12:53:38.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Minor updates: added a new date (2025-10-16) and a study status line (IPDSharing) for 2025-10-07, while removing an older date (2025-01-16).
    Difference
    0.7%
    Check dated 2025-10-20T06:39:35.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    7%
    Check dated 2025-10-05T17:35:09.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-28T10:52:18.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2 and removed the Back to Top control. These changes are minor and do not affect core content, pricing, stock, or time slots.
    Difference
    0.4%
    Check dated 2025-09-14T00:49:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.